ARCHIVES

Tivozanib Trumps Sorafenib In 1st-Line Renal Cancer Study

This article is from The Cancer Letter archive.

Vol. 35 No. 5 | May 25, 2012

Download PDF Visit The Full Archive

Related Articles

ASCO Highlights Seven of 4,000 Abstracts Submitted for Annual Meeting, June 3-7

May 27, 2011

Anthrax Found At Local P.O.

November 2, 2001

In Brief: Fishman La Jolla President Emeritus, Ruoslahti Succeeds Him; Ariz. Seeks Meyskins Replacement

January 13, 1989

Clinical Trials: Stories On Results Can Have Unintended Consequences

May 15, 1998

Phase II Study Shows Positive Results in Reducing Dry Mouth

October 25, 2013

In Brief: Survey Finds Americans Misinformed About Leading Cause Of Cancer Death

July 10, 1998